Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease

B Canal, AW McClure, JF Curran, M Wu… - Biochemical …, 2021 - portlandpress.com
SARS-CoV-2 is a coronavirus that emerged in 2019 and rapidly spread across the world
causing a deadly pandemic with tremendous social and economic costs. Healthcare …

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease

B Canal, R Fujisawa, AW McClure… - The Biochemical …, 2021 - pubmed.ncbi.nlm.nih.gov
SARS-CoV-2 is responsible for COVID-19, a human disease that has caused over 2 million
deaths, stretched health systems to near-breaking point and endangered economies of …

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease

B Canal, AW McClure, JF Curran, M Wu, R Ulferts… - Biochemical …, 2021 - cir.nii.ac.jp
抄録< jats: p> SARS-CoV-2 is a coronavirus that emerged in 2019 and rapidly spread across
the world causing a deadly pandemic with tremendous social and economic costs …

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease

B Canal, AW McClure, JF Curran, M Wu… - Biochemical …, 2021 - discovery.dundee.ac.uk
SARS-CoV-2 is a coronavirus that emerged in 2019 and rapidly spread across the world
causing a deadly pandemic with tremendous social and economic costs. Healthcare …

[HTML][HTML] Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease

B Canal, AW McClure, JF Curran, M Wu… - Biochemical …, 2021 - ncbi.nlm.nih.gov
SARS-CoV-2 is a coronavirus that emerged in 2019 and rapidly spread across the world
causing a deadly pandemic with tremendous social and economic costs. Healthcare …

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease.

B Canal, AW McClure, JF Curran, M Wu, R Ulferts… - 2021 - crick.figshare.com
SARS-CoV-2 is a coronavirus that emerged in 2019 and rapidly spread across the world
causing a deadly pandemic with tremendous social and economic costs. Healthcare …

[PDF][PDF] Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease

B Canal, R Fujisawa, AW McClure, TD Deegan… - Biochemical …, 2021 - academia.edu
SARS-CoV-2 is responsible for COVID-19, a human disease that has caused over 2 million
deaths, stretched health systems to near-breaking point and endangered economies of …

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease

B Canal, R Fujisawa, AW McClure… - Biochemical …, 2021 - portlandpress.com
SARS-CoV-2 is responsible for COVID-19, a human disease that has caused over 2 million
deaths, stretched health systems to near-breaking point and endangered economies of …

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease.

B Canal, AW McClure, JF Curran, M Wu… - Biochemical …, 2021 - search.ebscohost.com
SARS-CoV-2 is a coronavirus that emerged in 2019 and rapidly spread across the world
causing a deadly pandemic with tremendous social and economic costs. Healthcare …

[PDF][PDF] Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp14/nsp10 Exoribonuclease

B Canal, AW McClure, JF Curran, M Wu, R Ulferts… - scholar.archive.org
SARS-CoV-2 is a coronavirus that emerged in 2019 and rapidly spread across the world
causing a deadly pandemic with tremendous social and economic costs. Healthcare …